4

$PFE · Pfizer Inc.

November 3, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Pfizer Inc. filed a Form 4 with the SEC reporting a change in beneficial ownership by Albert Bourla, the company’s Chairman and Chief Executive Officer. The filing covers a transaction dated October 30, 2026, and was submitted on November 3, 2026.

According to the filing, Mr. Bourla acquired 20 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Each unit represents one phantom share of Pfizer common stock, and the units are settled in cash following his separation from service. The reported price for these units was $30.52. After the transaction, Mr. Bourla beneficially owned 783,828 phantom stock units directly.

The filing does not report any transactions in non-derivative securities such as actual common stock. It also indicates that the phantom stock units may be transferred by the reporting person into an alternative investment account at any time.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →